...
首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >Immunohistochemical study of VEGF, angiopoietin 2 and their receptors in the neovascularization following microinjection of C6 glioma cells into rat brain.
【24h】

Immunohistochemical study of VEGF, angiopoietin 2 and their receptors in the neovascularization following microinjection of C6 glioma cells into rat brain.

机译:将C6胶质瘤细胞显微注射到大鼠脑中后,VEGF,血管生成素2及其受体在新生血管形成中的免疫组织化学研究。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Recent papers suggest that two angiogenic factors (angiopoietin 2 and vascular endothelial growth factor) cooperate in tumoral angiogenesis to support the growing tumor. The purpose of the present work was to demonstrate the existence of such cooperation in a longitudinal study of a brain tumor model during tumor growth by means of immunohistochemistry. MATERIALS AND METHODS: The study was performed on 31 rats bearing C6 glioma. At different stages of tumor growth, the histological aspects were described and sections were immunostained for VEGF, Ang-2 and their receptors VEGFR-1, VEGFR-2 and Tie-2. Immunostaining was semi-quantitatively analyzed and the localization of immunostained cells was reported. RESULTS: Ang-2 and Tie-2 were detected in the endothelial cells of vessels surrounded by tumor cells, occuring early in our study, with immunostaining taking place from day 4 to day 24. Immunostaining with VEGF (on tumoral cells) and VEGFR-2 (on endothelial cells) was present after 8 days of tumor growth. A clear increase of vessel density can be observed at the periphery of the tumors after 16 days of tumor growth. At that time, areas of necrosis were present in the tumor with concomitant VEGF and Ang-2 expression. CONCLUSION: The present study demonstrated cooperation between the early effect of Ang-2 and the secondary effect of VEGF to elaborate new vessels in a longitudinal study of experimental brain tumors. This study is favorable to the new model of tumor angiogenesis, with successive vessel cooption, regression and growth mediated by angiopoietins and VEGF.
机译:背景:最近的研究表明,两种血管生成因子(血管生成素2和血管内皮生长因子)在肿瘤血管生成中相互配合,以支持不断增长的肿瘤。本工作的目的是通过免疫组织化学方法在肿瘤生长过程中脑肿瘤模型的纵向研究中证明这种合作的存在。材料与方法:这项研究是在31只患有C6神经胶质瘤的大鼠上进行的。在肿瘤生长的不同阶段,对组织学方面进行了描述,并对切片进行了VEGF,Ang-2及其受体VEGFR-1,VEGFR-2和Tie-2的免疫染色。对免疫染色进行半定量分析,并报告了免疫染色细胞的定位。结果:在我们研究的早期阶段,在被肿瘤细胞围绕的血管的内皮细胞中检测到了Ang-2和Tie-2,免疫染色从第4天到第24天进行。用VEGF(在肿瘤细胞上)和VEGFR-进行免疫染色。肿瘤生长8天后出现2个(在内皮细胞上)。在肿瘤生长16天后,可以在肿瘤周围观察到血管密度的明显增加。那时,肿瘤中存在坏死区域,并伴有VEGF和Ang-2表达。结论:本研究在实验性脑肿瘤的纵向研究中证明了Ang-2的早期作用与VEGF的次要作用之间的协作,以精制新血管。该研究有利于新的肿瘤血管生成模型,其具有由血管生成素和VEGF介导的连续血管共选择,消退和生长。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号